CLARISCAN 0.5 mmol/ml, solution for injection in a pre-filled syringe syringe, 20 ml
Active ingredients: Gadoteric acid, Gadoterate meglumine
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionsyringe, 20 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CLARISCAN 0,5 mmol/mL, solution injectable en seringue pré-remplie
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 seringue(s) préremplie(s) polycyclooléfine de 20 ml
- Marketing authorisation holder
- GE HEALTHCARE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 15 Jul 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63807217CIP73009186CIP133400930091869Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| GADOTÉRATE DE MÉGLUMINEsolution | — | SA |
| ACIDE GADOTÉRIQUEsolution | 279,3 mg · 1 mL de solution | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.